APA (7th ed.) Citation

Garg, M., de Jesus, A. A., Chapelle, D., Dancey, P., Herzog, R., Rivas-Chacon, R., . . . Sanchez, G. A. M. (2017). Rilonacept maintains long-term inflammatory remission in patients with deficiency of the IL-1 receptor antagonist. JCI insight, 2(16), . https://doi.org/10.1172/jci.insight.94838

Chicago Style (17th ed.) Citation

Garg, Megha, et al. "Rilonacept Maintains Long-term Inflammatory Remission in Patients with Deficiency of the IL-1 Receptor Antagonist." JCI Insight 2, no. 16 (2017). https://doi.org/10.1172/jci.insight.94838.

MLA (9th ed.) Citation

Garg, Megha, et al. "Rilonacept Maintains Long-term Inflammatory Remission in Patients with Deficiency of the IL-1 Receptor Antagonist." JCI Insight, vol. 2, no. 16, 2017, https://doi.org/10.1172/jci.insight.94838.